It is apparent that in these, and potentially other oncogenic settings, CDCP1 is the major substrate of Src family kinases (SFKs) and that it actively competes for Src with other mediators of pro-cancer phenotypes such as FAK [30]. This evidence concerns the gene SRC and cancer.